TrialTrove Software Subscription

2026-11-03

This combined synopsis / solicitation is a Request for Quotation ( RFQ ) prepared utilizing FAR Part 12 commercial item procedures and simplified acquisition procedures under FAR Part 13 . This announcement constitutes the only solicitation . Quotes are being requested , and a separate written solicitation will not be issued . This acquisition is being conducted as a full and open competition using competitive procedures , with a brand name specification in accordance with FAR 13 . 106 - 1 ( b ). This solicitation incorporates provisions and clauses by reference . The full text of provisions and clauses may be accessed electronically at https :// www . acquisition . gov and https :// www . acquisition . gov / hhsar . The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular ( FAC ( FAC ) 2025 - 06 October 1 , 2025 . All questions and inquiries concerning this solicitation must be submitted by e - mail only ( no faxes or telephone calls will be accepted ) to the Contract Specialistno later than February 20th , 2026 at 2 : 00pm Eastern Standard Time ( EST ). Questions must be emailed to the following addresses : Vera Nordalm via Vera . Nordalm @ hhs . gov , and copy Kwasi Antwi at Kwasi . Antwi @ hhs . gov and must reference “ TrialTrove Software Subscription – RFQ 75N98026Q00035 in the subject line . Quotes must be received no later than February 23rd , 2026 at 2 : 00pmEastern Standard Time ( EST ). Offerors must submit their quote to the following addresses : Vera Nordalm via Vera . Nordalm @ hhs . gov , and copy Kwasi Antwi at Kwasi . Antwi @ hhs . gov and must reference “ TrialTrove Software Subscription – RFQ 75N98026Q00035 in the subject line . This requirement is for a commercial Software as a Service ( SaaS ) subscription to the TrialTrove clinical trials database , to support oncology research activities conducted by the National Cancer Institute , Center for Cancer Research , Cancer Data Science Laboratory ( CDSL ). The TrialTrove database enables sophisticated querying and analysis across a wide range of clinical trial attributes , including disease indications , treatments , trial phase , sponsors , eligibility criteria , endpoints , outcomes , and trial timelines . TrialTrove also provides curated narratives of trial results and cross - references to original source materials , allowing researchers to validate and contextualize trial data . These capabilities are critical to CDSL ’ s mission and are not available through publicly accessible clinical trial databases . Please refer to the attached solicitation documents for the complete description of requirements .

Maryland

2026-05-02